George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,520.00
Bid: 5,515.00
Ask: 5,520.00
Change: 45.00 (0.82%)
Spread: 5.00 (0.091%)
Open: 5,505.00
High: 5,540.00
Low: 5,490.00
Prev. Close: 5,475.00
DCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

7 Feb 2018 07:00

RNS Number : 1135E
DCC PLC
07 February 2018
 

 

7 February 2018

 

DCC plc

 

Interim Management Statement

 

Trading in line with expectations and DCC Healthcare acquisition in US

 

DCC plc, the leading international sales, marketing and support services group, is issuing this Interim Management Statement for the third quarter ended 31 December 2017.

 

Third quarter ended 31 December 2017

Group operating profit for the third quarter ended 31 December 2017 was in line with expectations and ahead of the prior year.

 

Operating profit in DCC LPG was in line with expectations and the prior year, despite the headwind of an increasing cost of product. The mild weather conditions experienced early in the quarter impacted heating-related volumes modestly, although this was largely offset by good cost control. As previously announced, the French business launched its consumer natural gas and electricity initiative during the quarter and continues to invest in the development of its offering.

 

DCC Retail & Oil recorded good growth in operating profit, driven by strong organic profit growth in Denmark and Fuel Card. The business in Britain performed in line with expectations.

 

DCC Healthcare recorded strong growth in operating profit. DCC Vital delivered good organic profit growth, particularly in medical devices, and also benefited from the acquisition of Medisource completed during the prior year. DCC Health & Beauty Solutions again delivered strong growth in nutritional products.

 

Operating profit in DCC Technology was ahead of the prior year, benefiting from acquisitions and a good organic performance from the UK and Ireland, DCC Technology's largest business, where strong growth was achieved in the key product areas of audio visual, smart home and enterprise. The French consumer products business remains challenging and a number of operational changes are underway to improve performance. The remaining Continental European businesses continued to perform well and traded in line with expectations.

 

Year to 31 March 2018

Notwithstanding the mild start to the fourth quarter, particularly in France, DCC expects that both operating profit and adjusted earnings per share will be well ahead of the prior year and in line with current market consensus.

Development activity

The year to date has been very active from a development perspective. Reflecting the announced acquisition activity, the Group's cash spend on acquisitions in the current financial year will be approximately £670 million.

 

Today's announcement by DCC Healthcare of the acquisition of Elite One Source Nutritional Services, Inc ("Elite") is an exciting step in the expansion of DCC Health & Beauty Solutions. The acquisition is the business' first step into the growing US market, the world's leading healthcare and dietary supplements market. Based in Missoula, Montana, Elite is a provider of contract manufacturing and related services to leading specialist brands in the US consumer healthcare market. The business, led by an experienced management team, employs 180 people and operates from well-invested facilities which comply with FDA cGMP and Health Canada standards and are certified by leading third party regulatory bodies. The consideration, based on an enterprise value of $50 million (£35 million), was paid in cash on completion. Elite is expected to generate a return on capital employed of approximately 15% within the first two years of ownership.

 

The completion processes for the previously announced acquisitions of Retail West, TEGA and Countrywide are progressing to plan and all transactions are expected to complete by the end of the current financial year.

 

DCC remains ambitious to continue the growth and development of its business in existing and new geographies and retains a strong, well-funded and liquid balance sheet.

 

Final results

DCC expects to announce its results for the year to 31 March 2018 on 15 May 2018.

 

 

For reference:

Donal Murphy, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Capital Markets

 

Telephone: +353 1 2799400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

Powerscourt (Media)

Lisa Kavanagh / Victoria Palmer-Moore

 

Telephone: +44 20 7250 1446

Email: DCC@powerscourtgroup.com

 

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology.

 

DCC is an ambitious and entrepreneurial business operating in 15 countries, supplying products and services used by millions of people every day throughout Europe. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

 

Headquartered in Dublin, employing approximately 10,000 people, DCC’s four divisions are:
· DCC LPG - a leading LPG sales and marketing business with operations in Europe and Asia and a developing business in the retailing of natural gas and electricity;
· DCC Retail & Oil - a leader in the sales, marketing and retailing of transport fuels and commercial fuels, heating oils and related products and services in Europe;
· DCC Healthcare - a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners; and
· DCC Technology - a leading European sales, marketing and services partner for global technology brands. 

DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2017, DCC generated revenue of £12.3 billion and operating profit of £345 million.

 

DCC has an excellent record, delivering compound annual growth of 14% in operating profit and generating an average return on capital employed of approximately 19% over 23 years as a public company.

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDQLFBVLFEBBE
Date   Source Headline
17th May 20227:00 amRNSResults for the year ended 31 March 2022
7th Apr 20227:00 amRNSDCC plc Upcoming Events
28th Feb 202210:44 amRNSTotal Voting Rights
15th Feb 20227:00 amRNSDCC Technology Presentation and Webcast
8th Feb 20227:00 amRNSBoard Changes
8th Feb 20227:00 amRNSInterim Management Statement
3rd Feb 202211:54 amRNSDCC Technology Presentation and Webcast
15th Dec 20217:00 amRNSDCC Management Presentation
15th Dec 20217:00 amRNSDCC plc acquires Almo Corporation
30th Nov 20214:31 pmRNSTotal Voting Rights
26th Nov 20217:15 amRNSDirector Declaration
15th Nov 20214:25 pmRNSDirector/PDMR Shareholding
11th Nov 20214:58 pmRNSDirector/PDMR Shareholding
11th Nov 202111:25 amRNSDirector/PDMR Shareholding
9th Nov 202110:01 amRNSUpdate on Timing of Interim Results Announcement
9th Nov 20217:00 amRNSBoard Changes
9th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
28th Sep 20217:00 amRNSDCC Healthcare Event
14th Sep 20212:33 pmRNSDCC Healthcare Event
16th Jul 20212:17 pmRNSResult of AGM
16th Jul 20217:00 amRNSBoard Changes
16th Jul 20217:00 amRNSInterim Management Statement
13th Jul 20217:10 amRNS2021 Sustainability Report
7th Jul 20217:01 amRNSMr Cormac McCarthy
17th Jun 202112:34 pmRNS2021 Annual Report, Notice of AGM and Proxy Form
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20215:47 pmRNSDirector/PDMR Shareholding
20th May 20219:45 amRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSAppointment of Chairman Designate & Board Renewal
18th May 20217:00 amRNSResults for the year ended 31 March 2021
23rd Apr 20217:14 amRNSDirector Declaration
1st Apr 20217:13 amRNSDirector Declaration
23rd Mar 20217:06 amRNSDirector Declaration
15th Mar 20217:00 amRNSDCC Healthcare acquires primary care supplier
11th Mar 20219:12 amRNSUpdate on the Migration to Euroclear Bank
26th Feb 202112:26 pmRNSTotal Voting Rights
18th Feb 20212:12 pmRNSDCC Consents to Migration of Ordinary Shares
11th Feb 20215:02 pmRNSDirector/PDMR Shareholding
4th Feb 20215:01 pmRNSDirector/PDMR Shareholding
4th Feb 20211:46 pmRNSResult of EGM
2nd Feb 20217:00 amRNSInterim Management Statement
26th Jan 20217:43 amRNSDirector Declaration
7th Jan 20214:55 pmRNSHolding in Company TR-1
7th Jan 20217:36 amRNSNotice of Extraordinary General Meeting
5th Jan 20217:00 amRNSDCC Significantly Expands Presence - US LPG market
27th Nov 20202:31 pmRNSTotal Voting Rights
18th Nov 202010:05 amRNSEnabling energy transition webcast
17th Nov 202010:16 amRNSDirector/PDMR Shareholding
13th Nov 20203:40 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSResults for the six months ended 30 September 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.